SOURCES SOUGHT
A -- Phantoms for evaluatin of digital breast tomosynthesis
- Notice Date
- 7/18/2011
- Notice Type
- Sources Sought
- NAICS
- 334517
— Irradiation Apparatus Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, Bldg 50 Room 422, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 1090237a
- Archive Date
- 8/13/2011
- Point of Contact
- Marcia O Park, Phone: (870) 543-7405
- E-Mail Address
-
marcia.park@fda.hhs.gov
(marcia.park@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- This notice is for Market Research purposes only, not a request for proposal or solicitation. The Food and Drug Administration (FDA) is seeking sources, including service-disabled veteran-owned small businesses, HUBzone small businesses, 8(a) certified small businesses, woman owned small businesses, small disadvantaged businesses as well as small businesses. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for providing the items below. The North American Industry Classification System (NAICS) code is 334517 - Irradiation Apparatus Manufacturing with a small business size standard of 500 employees. The FDA is interested in purchasing phantoms to support a research project on digital breast tomosynthesis. The first of two phantom types is intended to permit quantitative measurement of the degree to which out-of plane structures in the object being imaged appear in the plane of interest in a tomosynthesis image stack. The structure shall be of 3-dimensional small-diameter (around 1 mm) rod like structures embedded in breast-tissue equivalent material which shall be the same as the overall size and shape of existing anthropomorphic phantoms that simulate an average breast. The second of the two phantom types is intended for a study to determine experimentally the effect that reducing breast compression has on image quality in digital breast tomosynthesis. The phantom shall match approximately a "D cup" size breast, with an uncompressed thickness of 5 to 6 cm and must be compressible. The period of performance will have a base period of three months, with 4 option periods for a total period of performance of 11 months. The order will also have an option for ordering increased quantities during the period of performance. Potential contractors must indicate business size, proof of any set-aside certification and company's DUNS number and provide a contact name, the mailing address, phone number and email address of point of contact. Capability statement must provide enough information to determine if company can meet requirements stated above by including technical specifications, descriptive literature, brochures and other information that demonstrates the capabilities of the contractor to meet the requirements. Provide two contact names, email and phone numbers for user of the proposed system that may be contacted by the Government. Identify availability under GSA contract if applicable. Responses are due in person, by postal mail or by email to the point of contact listed below on or before July 29, 2011 by 1:00 P.M. CDT at the Food and Drug Administration, OC/OA/OAGS, Attn: Marcia Park, 3900 NCTR Road, HFT-322, Jefferson, AR, 72079-9502. Reference 1090237. Questions regarding this posting shall be submitted via email not later than 1:00 PM CDT on July 27, 2011. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by the respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a solicitation may be published in the Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in a resultant solicitation that may result from this market survey. For information regarding this notice, contact Marcia Park, 870/543-7405, FAX 870543-7990 or email marcia.park@fda.hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/1090237a/listing.html)
- Place of Performance
- Address: Food and Drug Administration, White Oak Campus, Building 62, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN02501940-W 20110720/110719000139-147a03dc298a44a404f37feed91a91af (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |